Details

Last Funding Type

Series C

Last Funding Money Raised

$44M

Industries

Biopharma,Biotechnology,Health Care,Life Science,Pharmaceutical

Founded date

Jan 1, 2009

Number Of Employee

11 - 50

Operating Status

Active

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.